tiprankstipranks
Aeglea Biotherapeutics Inc (AGLE)
NASDAQ:AGLE
US Market

Aeglea Biotherapeutics (AGLE) Stock Investors

344 Followers
Based on 704,996 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold AGLE
On average, investors allocate 1.61% of their portfolios to AGLE
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Negative
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 704,996 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding AGLE

0.8%
Last 7
Days
3.9%
Last 30
Days
Percentages indicate the change in the number of portfolios holding AGLE, out of 704,996 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

AGLE Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$12.01
Opened
0.02%
$14.38
Based on the activity of 12,931 investors who made their portfolios public
The table shows changes in AGLE in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

AGLE Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.34%
-0.67%
-5.70%
229.41M
Healthcare
Assertio Therapeutics
2.78%
-0.82%
-6.00%
115.50M
Healthcare
Micron
5.60%
+0.12%
-2.29%
84.41B
Technology
Marvell
4.84%
+0.06%
-1.93%
48.34B
Technology
Merck & Company
4.31%
+0.17%
-0.61%
258.14B
Healthcare
AMC Entertainment
5.32%
-0.27%
-3.23%
1.37B
Communication Services
Delta Air Lines
5.60%
-0.22%
-1.41%
23.23B
Industrials
Raytheon Technologies
4.06%
+0.30%
-1.84%
115.00B
Industrials
Snap
9.82%
-0.36%
-4.02%
20.61B
Communication Services
Boeing
6.41%
+0.42%
+2.26%
133.09B
Industrials
Based on the activity of 704,996 active portfolios
Open your Smart Portfolio

AGLE Investor Analysis

AGLE investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
7.3%
of AGLE holders
are under 35
Average Segment Performance
Average P/E Ratio19.24
Beta8.50
Dividend Yield7.32%
AGLE investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
62.2%
of AGLE holders
are between 35–55
Average Segment Performance
Average P/E Ratio17.11
Beta12.65
Dividend Yield8.03%
AGLE investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
30.5%
of AGLE holders
are over 55
Average Segment Performance
Average P/E Ratio15.73
Beta5.73
Dividend Yield7.66%
Overview of age group and performance of AGLE stock investors
See who invests in AGLE according to age group and performance.

FAQ

How many retail Investors hold AGLE?
<0.1% of TipRanks' retail investors hold AGLE in their portfolios.
    What is AGLE Investor Sentiment?
    AGLE’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of AGLE in the last 7 days?
      ▼ 0.8% of TipRanks' retail investors changed their holding of AGLE in the last 7 days.
        What percentage of retail investors changed their holding of AGLE in the last 30 days?
        ▼ 3.9% of TipRanks' retail investors changed their holding of AGLE in the last 30 days.
          What is the average age of retail investors who hold AGLE?
          The average age of AGLE Holders is between 35–55.
            What other stocks have AGLE investors also bought?
            AGLE Investors also bought CHRS, ASRT, MU, MRVL, MRK, AMC, DAL, RTX, SNAP, BA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALNYAlnylam Pharma
              ATECAlphatec Holdings
              BDXBecton Dickinson
              BCRXBioCryst
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis